Cargando…
Correction to: Remdesivir: A Review in COVID-19
Autor principal: | Blair, Hannah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511569/ https://www.ncbi.nlm.nih.gov/pubmed/37665470 http://dx.doi.org/10.1007/s40265-023-01937-x |
Ejemplares similares
-
Remdesivir: A Review in COVID-19
por: Blair, Hannah A.
Publicado: (2023) -
Correction to: Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Additional Benefit
por: Sun, Duxin
Publicado: (2020) -
Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis
por: Tempestilli, Massimo, et al.
Publicado: (2022) -
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
por: Blair, Hannah A.
Publicado: (2019) -
Correction to: Tiotropium/Olodaterol: A Review in COPD
por: Blair, Hannah A.
Publicado: (2019)